期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

正确应对不动杆菌肺部感染 被引量：10

下载PDF
导出
摘要 自上世纪90年代以来,多耐药非发酵革兰阴性杆菌开始成为医院感染的重要病原菌,并迅速增加,其中不动杆菌（Acinetobacter）尤其令人关注。鲍曼不动杆菌（Acinetobacter baumannii）或称鲍曼-醋酸钙不动杆菌复合群,占不动杆菌的80%～90%,
作者 施毅
机构地区 南京军区南京总医院呼吸与危重症医学科
出处 《中国呼吸与危重监护杂志》 CAS 2012年第1期13-14,共2页 Chinese Journal of Respiratory and Critical Care Medicine
关键词 不动杆菌肺部感染 非发酵革兰阴性杆菌 醋酸钙不动杆菌 鲍曼不动杆菌 医院感染 病原菌 多耐药 复合群
分类号 R446.5 [医药卫生—诊断学]
  • 相关文献

参考文献9

  • 1Gaynes R, Edwards JR; National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis,2005,41:848-852.
  • 2朱德妹,汪复,胡付品,蒋晓飞,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,陈中举,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,王爱敏,张泓,孔菁,徐元宏,沈继录,单斌,杜艳.2010年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2011,11(5):321-329. 被引量：651
  • 3Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis,2010,51 :S81-S87.
  • 4俞云松.多药耐药鲍曼不动杆菌——21世纪革兰阴性菌的“MRSA”[J].中华临床感染病杂志,2009,2(2):65-68. 被引量：93
  • 5Munoz-Price IS, Weinstein RA. Acinetobacter infection. N Engl J Med ,2008,358 : 1271-1281.
  • 6Levin AS, Levy CE, Manrique AE, et al. Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. Int J Antimicrob Agents,2003,21:58-62.
  • 7Betrosian AP,Frantzeskaki F, Xanthaki A, et al. Efficacy and safety of high-dose ampieillin/sulbaetam vs. eolistin as monotherapy for the treatment of muhidrug resistant Acinetobacter baumannii ventilator- associated pneumonia. J Infect,2008,56:432-436.
  • 8Kiffer CR, Sampaio JL, Sinto S, et al. In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii. Diag Microbiol Infect Dis,2005,52:317-332.
  • 9Towner KJ. Acinetobacter:an old friend, but a new enemy. J Hospit Infect, 2009,73 : 355-363.

二级参考文献11

  • 1Arias CA,Murray BE.Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med,2009,360(5):439-443.
  • 2Clinical and Laboratory Standads Institute.Performance Standards for Antimicrobial Susceptibility Testing[S].Fifteenth Informational Supplement,2010,M100-S20 Vol 30 No.1.
  • 3Clinical and Laboratory Standads Institute Performance Standards for Antimicrobial Susceptibility Testing[S].Fifteenth Informational Supplement,2010,M100-S20-U Vol 30 No 15.
  • 4Clinical Laboratory Standard Institute.Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria[S].Approved Guideline M45-A,Vol.26 No.19,2006.
  • 5Wang P,Hu FP,Xiong ZZ,et al.Susceptibility of ESBL-Producing nterobacteriaceae with the New CLSI Breakpoints[J].J Clin Microbiol,2011,49(6):3127-3131.
  • 6Yang Q,Wang H,Sun H,et al.Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems:results from large hospital-based surveillance studies in China[J].Antimicrob Agents Chemother,2010,54(1):573-577.
  • 7Wang H.Guo P,Sun HL,et al.Molecular epidemiology of clinical isolates of carbapenem-resistant Acinerobacter spp from Chinese hospitals[J].Antimicrob Agents Chemother.2007,51(11):4022-4028.
  • 8沈继录,朱德妹,吴卫红,徐晓刚,王明贵.革兰阴性杆菌碳青霉烯酶产生与细菌耐药性关系的研究[J].中华检验医学杂志,2008,31(4):408-414. 被引量：66
  • 9冯雅君,沈萍,杜小幸,俞云松,李兰娟.产碳青霉烯酶KPC-2肺炎克雷伯菌局部流行[J].浙江医学,2008,30(9):923-925. 被引量：61
  • 10汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,李丽,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华,徐元宏,沈继录,单斌,杜艳.2009年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2010,10(5):325-334. 被引量：397

共引文献736

同被引文献76

  • 1戚其学,王春雷,李艳玲.169例非发酵革兰阴性杆菌所致院内获得性肺炎的危险因素及耐药性分析[J].中国血液流变学杂志,2007,17(2):290-292. 被引量：19
  • 2American Thoracic Society: Infectious Diseases Society of A- merica. Guidelines for the management of adults with hospi- tal-acquired, Ventilator-associated, and health care associated pneumonia[J]. Am J Respir Crit Care Med, 2005,171 (4) : 388-416.
  • 3Andermahr J,Greb A, Hensler T, et al. Pneumonia in multi pie injured patients: a prospective controlled trial on early prediction using clinical and immunological parameters [J]. lnflamm Res,2002,51(5) :265-272.
  • 4Papadomichelakis E, Kontopidou F, Antoniadou A, et al. Screening for resistant gram-negative microorganisms to guide empiric therapy of suhsequeat infection[J]. Inten- sive Care Med,2008,34(12) :2169-2175.
  • 5Michalopoulos A, Falagas ME, Karatza DC, et al. Epide miologic,elinical characteristics, and risk factors for ad verse outcome in multi-resistant gram-negative primary bacteremia of critically ill patients[J]. Am J Infect Con- trol,2011,39(5) :396- 400.
  • 6Jeong SH,Bae IK,Kwon SB,et al. Investigation of a nos ocomial outbreak of cinetobaeter baumannii producing PER 1 extended spectrum β-lactamase in an ICU[J]. Hosp Infect,2005,59(3) :242-248.
  • 7Wilkinson TM, Patel IS, Wilks M, et al. Airway bacterial load and FEVI decline in patients with chronic obstruc- tive pulmonary disease[J]. Am J Respir Crit Care Med, 2003,167(8) : 1090-1095.
  • 8Jensen JU,HEIN IJ,Lundgren B, et al. Procalcitonin and antibiotic escalation in critical care patients not a good i dea[J]. Clin Infect Dis,2012+54(10) : Ⅲ-Ⅳ.
  • 9Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emer- gence of a successful pathogen[ J]. Clin Microbiol Rev, 2008, 21 (3): 538-582.
  • 10Clinical and Laboratory Standads Institute. Performance Standards for Antimicrobial Susceptibility Testing [ S ]. Sixteenth Informational Supplement, 2009, M100-S19.

引证文献10

二级引证文献79

中国呼吸与危重监护杂志
2012年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部